Search research articles
Contact Us
Filters
Showing results (81-90 of 133) with videos related to
Page
of 14
Sort By:
Neuropharmacology
|
December 3, 2014
Knockdown of ventral tegmental area mu-opioid receptors in rats prevents effects of social defeat stress: implications for amphetamine cross-sensitization, social avoidance, weight regulation and expression of brain-derived neurotrophic factor
Caitlin E Johnston, Daniel J Herschel, Amy W Lasek, et al.
Frontiers in Pharmacology
|
September 2, 2017
Anaplastic Lymphoma Kinase Is a Regulator of Alcohol Consumption and Excitatory Synaptic Plasticity in the Nucleus Accumbens Shell
Regina A Mangieri, Esther Y Maier, Tavanna R Buske, et al.
Oncology Reports
|
December 22, 1999
Potentiatied anti-tumor effectiveness of combined therapy with interleukin-12 and mitoxantrone of L1210 leukemia in vivo
J Golab, R Zagozdzon, K Kozar, et al.
Archivum Immunologiae Et Therapiae Experimentalis
|
January 1, 1994
Synergistic antiproliferative activity of tumor necrosis factor alpha (TNF-alpha) and lovastatin
M K Sora, A A Kruszewski, T Stokłosa, et al.
International Journal of Cancer
|
August 4, 1998
Effective chemo-immunotherapy of L1210 leukemia in vivo using interleukin-12 combined with doxorubicin but not with cyclophosphamide, paclitaxel or cisplatin
R Zagozdzon, J Gołab, T Stokłosa, et al.
Alcohol, Clinical & Experimental Research
|
February 20, 2024
Histone deacetylase inhibitor decreases hyperalgesia in a mouse model of alcohol withdrawal-induced hyperalgesia
Jhoan Aguilar, Luana Martins De Carvalho, Hu Chen, et al.
Molecular Psychiatry
|
August 3, 2023
Conserved role for PCBP1 in altered RNA splicing in the hippocampus after chronic alcohol exposure
Luana Carvalho, Hu Chen, Mark Maienschein-Cline, et al.
Cancer Immunology, Immunotherapy : CII
|
December 9, 1997
Antitumor effects of the combination immunotherapy with interleukin-12 and tumor necrosis factor alpha in mice
W Lasek, W Feleszko, J Golab, et al.
Alcohol (Fayetteville, N.Y.)
|
March 10, 2019
The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) alleviates depression-like behavior and normalizes epigenetic changes in the hippocampus during ethanol withdrawal
Wei-Yang Chen, Huaibo Zhang, Eleonora Gatta, et al.
Alcoholism, Clinical and Experimental Research
|
August 14, 2018
Histone Deacetylase Inhibitor Suberanilohydroxamic Acid Treatment Reverses Hyposensitivity to γ-Aminobutyric Acid in the Ventral Tegmental Area During Ethanol Withdrawal
Chang You, Bertha J Vandegrift, Huaibo Zhang, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 133) with videos related to
Sort By:
Page
of 14
Neuropharmacology
|
December 3, 2014
Knockdown of ventral tegmental area mu-opioid receptors in rats prevents effects of social defeat stress: implications for amphetamine cross-sensitization, social avoidance, weight regulation and expression of brain-derived neurotrophic factor
Caitlin E Johnston, Daniel J Herschel, Amy W Lasek, et al.
Frontiers in Pharmacology
|
September 2, 2017
Anaplastic Lymphoma Kinase Is a Regulator of Alcohol Consumption and Excitatory Synaptic Plasticity in the Nucleus Accumbens Shell
Regina A Mangieri, Esther Y Maier, Tavanna R Buske, et al.
Oncology Reports
|
December 22, 1999
Potentiatied anti-tumor effectiveness of combined therapy with interleukin-12 and mitoxantrone of L1210 leukemia in vivo
J Golab, R Zagozdzon, K Kozar, et al.
Archivum Immunologiae Et Therapiae Experimentalis
|
January 1, 1994
Synergistic antiproliferative activity of tumor necrosis factor alpha (TNF-alpha) and lovastatin
M K Sora, A A Kruszewski, T Stokłosa, et al.
International Journal of Cancer
|
August 4, 1998
Effective chemo-immunotherapy of L1210 leukemia in vivo using interleukin-12 combined with doxorubicin but not with cyclophosphamide, paclitaxel or cisplatin
R Zagozdzon, J Gołab, T Stokłosa, et al.
Alcohol, Clinical & Experimental Research
|
February 20, 2024
Histone deacetylase inhibitor decreases hyperalgesia in a mouse model of alcohol withdrawal-induced hyperalgesia
Jhoan Aguilar, Luana Martins De Carvalho, Hu Chen, et al.
Molecular Psychiatry
|
August 3, 2023
Conserved role for PCBP1 in altered RNA splicing in the hippocampus after chronic alcohol exposure
Luana Carvalho, Hu Chen, Mark Maienschein-Cline, et al.
Cancer Immunology, Immunotherapy : CII
|
December 9, 1997
Antitumor effects of the combination immunotherapy with interleukin-12 and tumor necrosis factor alpha in mice
W Lasek, W Feleszko, J Golab, et al.
Alcohol (Fayetteville, N.Y.)
|
March 10, 2019
The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) alleviates depression-like behavior and normalizes epigenetic changes in the hippocampus during ethanol withdrawal
Wei-Yang Chen, Huaibo Zhang, Eleonora Gatta, et al.
Alcoholism, Clinical and Experimental Research
|
August 14, 2018
Histone Deacetylase Inhibitor Suberanilohydroxamic Acid Treatment Reverses Hyposensitivity to γ-Aminobutyric Acid in the Ventral Tegmental Area During Ethanol Withdrawal
Chang You, Bertha J Vandegrift, Huaibo Zhang, et al.
Page
of 14